Skip to content
Screener

Gilead Sciences GILD Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$152.27B+14.9%
Incyte logo
IncyteINCY
$18.7B+63.4%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$8.16B+187%
Precigen logo
PrecigenPGEN
$1.46B+234%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.35B+176%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.3B+33.2%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$161.66B+13.5%
P/E17.5×-5.0×
P/S5.4×+0.5×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio2×+0.6×

Where this comes from

Calculated from Gilead Sciences’s reported figures.

$172.99Bmarket cap+$22.2Btotal debt−$7.6Bcash and equivalents=$187.53B

The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 5:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000882095-26-000024

FAQ

What is Gilead Sciences's enterprise value?
Gilead Sciences (GILD) reported enterprise value of $187.53B in Q1 2026.
How has Gilead Sciences's enterprise value changed year-over-year?
Gilead Sciences's enterprise value increased by 19.7% year-over-year, from $156.71B to $187.53B.
What is the long-term trend for Gilead Sciences's enterprise value?
Over 5 years (2020 to 2025), Gilead Sciences's enterprise value has grown at a 11.4% compound annual growth rate (CAGR), from $99.2B to $170.26B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Gilead Sciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude